Oral sarecycline for treatment of papulopustular rosacea: Results of a pilot study of effectiveness and safety

Keyphrases

• Sarecycline 100%
• Papulopustular Rosacea 100%
• Acne 30%
• Percentage Reduction 20%
• Lesion Count 20%
• Narrow Spectrum 20%
• Inflammatory Lesions 20%
• Global Rankings 20%
• Low Risk 10%
• Once-daily 10%
• Moderate to Severe 10%
• Efficacy Endpoint 10%
• Tolerability 10%
• Erythema 10%
• Risk Reduction 10%
• Pruritus 10%
• Tetracycline 10%
• Inflammatory Skin Diseases 10%
• Absolute Reductions 10%
• Adult Subjects 10%
• FDA-approved Drugs 10%
• Doxycycline 10%
• Minocycline 10%
• Oral Dosing 10%
• Weight-based 10%
• Rosaceae 10%
• Resistant Bacteria 10%
• Antibiotic Activity 10%
• Papulonodular Lesions 10%
• Multivitamin Tablets 10%

Medicine and Dentistry

• Sarecycline 100%
• Rhinophyma 100%
• Papulopustular 100%
• Acneiform Eruption 30%
• Serositis 20%
• Dermatosis 10%
• Side Effect 10%
• Erythema 10%
• Multivitamin 10%
• Thermal Burn 10%
• Pruritus 10%
• Doxycycline 10%
• Minocycline 10%
• Tetracycline 10%
• Antimicrobial Activity 10%
• Antimicrobial Agent 10%